ABSTRACT
Importance Substantial racial/ethnic disparities in COVID-19 mortality have been documented. Social class is a likely explanation of mortality disparities across and within racial/ethnic groups. This is the first U.S. study of social class and COVID-19 mortality in working age adults.
Objectives To determine the joint effects of social class, race/ethnicity, and gender on the burden of COVID-19 mortality. A secondary objective was to determine whether differences in opportunities for remote work were correlated with COVID-19 death rates for sociodemographic groups.
Design Annual mortality study which used a special government tabulation of 2020 COVID-19 related deaths stratified by decedents’ social class (educational attainment) and race/ethnicity.
Setting United States in 2020.
Participants COVID-19 decedents aged 25 to 64 years old (n=69,001).
Exposures Social class (working class, some college, college graduate), race/ethnicity (Hispanic, Black, Asian, Indigenous, multiracial, and non-Hispanic white), and gender (women, men). Detailed census data on occupations held by adults in 2020 in each of the 36 sociodemographic groups studied were used to quantify the possibility of remote work for each group.
Main Outcomes and Measures Age-adjusted COVID-19 death rates for 36 sociodemographic groups defined by social class, race/ethnicity, and gender. Disparities were quantified by relative risks and 95% confidence intervals. College graduates were the (low risk) referent group for all relative risk calculations.
Results A higher proportion of Hispanics, Blacks, and Indigenous people were working class in 2020. COVID-19 mortality was five times higher in the working class vs. college graduates (72.2 vs. 14.6 deaths per 100,000, RR=4.94, 95% CI 4.82-5.05). The joint detriments of lower socioeconomic position, Hispanic ethnicity, and male gender resulted in a COVID-19 death rate which was over 27 times higher (178.0 vs. 6.5 deaths/100,000, RR=27.4, 95%CI 25.9-28.9) for working class Hispanic men vs. college graduate white women. In regression modeling, percent employed in never remote jobs explained 72% of the variance in COVID-19 death rates.
Conclusions and Relevance SARS-CoV-2 infection control efforts should prioritize the working class (i.e. those with no college education), particularly those employed in “never remote” jobs with inflexible and unsafe working conditions (i.e. blue collar, service, and retail sales workers).
Question Did COVID-19 mortality rates among non-elderly adults vary significantly by social class, race/ethnicity, and gender in 2020?
Findings Among 69,001 COVID-19 decedents, age-adjusted COVID-19 deaths rates were 5 times higher in working class vs. college graduate adults 25-64 years old. Working class Hispanic, Black, and Indigenous men suffered the highest burden of COVID-19 mortality, while college graduate white women experienced the lowest death rate.
Meaning COVID-19 mitigation efforts should prioritize the working class (i.e. those with no college education), particularly blue collar, service, and retail sales workers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involved only openly available mortality data, which can be obtained from the National Center for Health Statistics: https://www.cdc.gov/nchs/covid19/covid-19-mortality-data-files.htm
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Competing Interest Statement: None.
Data Availability
All data analyzed in this study are publicly available online.
